Developer docs
API playgroundTry for free, no card

Search company profiles

PainDrainer

Full company profile

uuid0002in2

Namestring
PainDrainer
Legal namestring
Paindrainer AB
Websiteurl
paindrainer.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

PainDrainer AB is a Swedish digital therapeutics company founded in 2018 at Medicon Village in Lund by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement, and Göran Barkfors. The company operates the PD Care System, a prescription-only digital therapeutic for adults (18+) with chronic non-malignant pain lasting longer than three months, including back, neck, fibromyalgia, joint, and nerve pain. The platform combines a patient-facing mobile app with a cloud-based clinic portal (clinic-us.paindrainer.com) that allows healthcare providers to prescribe the intervention and conduct Remote Therapeutic Monitoring (RTM). The system is CE-marked and FDA-registered (Rx-only under 21 CFR Part 11), with HIPAA, GDPR, and SOC2 compliance, and is anchored on a 12-week CARE program built on Acceptance and Commitment Therapy (ACT).

The core technology is a proprietary artificial intelligence network that ingests structured daily activity logs (sleep, work, rest, leisure, exercise), pain scores, medication adherence, and goals, and after approximately seven logged days produces personalized daily recommendations that balance activity with acceptable pain thresholds. The proprietary method is protected by European patent EP 4186064 (allowable) and parallel applications pending in the US, Canada, Japan, and South Korea. The platform architecture supports a future direct-to-consumer product called Relivra, which is positioned for individuals not connected to partner providers. PainDrainer has co-development and clinical-study partnerships with UC San Diego Health, Weill Cornell Medicine, Newton-Wellesley Hospital, and Lund University, and has published peer-reviewed outcomes in Pain Medicine (2023) and Annals of Clinical Case Reports (2022). Named customers/endorsers include clinical leaders at New York Presbyterian Hospital and the American Academy of Pain Medicine.

PainDrainer's business model is a recurring subscription for the consumer app (99 SEK / ~$9–10 USD per month with a 14-day free trial, payable in Sweden via employer friskvårdsbidrag wellness benefits), paired with a prescription-mediated provider channel in the US where RTM services are billed under CMS RTM codes. Commercial rollout into the US market was funded by a SEK 10 million share issue completed in February 2023, supplemented by additional rounds in December 2021 (~USD 1.37M, Almi Invest-led) and March 2025 (~USD 912K with Almi Invest, Rethink Capital, Tramontane Invest). Active geographies are Sweden (EMEA) and the United States (North America), and the company operates with 1–10 employees.

Short descriptiontext

PainDrainer AB operates a CE-marked, FDA-registered prescription digital therapeutic that uses a proprietary AI network to personalize chronic pain management through daily activity-pain correlation analysis. The PD Care System serves US healthcare providers and adult chronic pain patients via subscription, with operations in Sweden and the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLund, Sweden
HQ citystring
Lund
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital therapeutics platform, chronic pain management, remote therapeutic monitoring, prescription digital therapeutic, AI activity recommendations
Industry4 codes
PRIMARYHLACANAA
Condition-specific Digital Therapeutics (DTx)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAFABAH
Pain Management Clinics (Interventional & Medical)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
NAICS code3 codes
  • Computer Systems Design and Related Services54151
  • Custom Computer Programming Services541511
  • Home Health Care Services62161
SIC code2 codes
  • Services-Health Services8000
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Digital Therapeutics for Chronic Pain Management
Social media profiles2 records
Revenue model1 record
1Subscription - PD Care System
TypeSubscription Recurring
Description

Monthly subscription model for the PainDrainer app and PD Care system. Users receive a 14-day free trial before subscription charges begin. The subscription provides access to the complete CARE program, personalized recommendations after 7 logged days, and all app features including activity planning, pain tracking, and rehabilitation exercises.

paindrainer.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Standard monthly subscription with 14-day free trial
ModelSubscriptionBilling cadenceMonthly
Notes

99 SEK per month (approximately $9-10 USD). Includes full access to all app features, the CARE program, personalized daily recommendations, and rehabilitation exercises designed by chronic pain management experts.

paindrainer.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 record
1PD Care System
Description

A complete Remote Therapeutic Monitoring (RTM) solution designed to integrate personalized treatment and medication management into one single platform for chronic pain management.

paindrainer.com
Core offering1 text field

PainDrainer develops and sells the PD Care System, a prescription-only digital therapeutic and Remote Therapeutic Monitoring (RTM) platform for adults with chronic pain lasting more than three months. The platform combines a patient mobile app, a cloud-based Care Portal for healthcare professionals, and a proprietary AI network that analyzes individual activity and pain data to deliver personalized daily activity recommendations and a 12-week CARE rehabilitation program. The product is registered as a medical device (CE-marked and FDA-registered) and is prescribed by healthcare providers to address conditions such as back pain, neck pain, fibromyalgia, joint pain, and nerve pain.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 72.5% improved physical function after 12 weeks using PD Care system
+4 more records
Product overview1 text field

Paindrainer offers a unified digital health platform centered on the PD Care System, combining a prescription-only mobile app for chronic pain patients with a cloud-based Care Portal for healthcare professionals. The platform provides Remote Therapeutic Monitoring (RTM) services, featuring the 12-week CARE Program, AI-powered personalized activity recommendations, rehabilitation exercises, and relaxation/mindfulness practices. Healthcare providers can prescribe the solution through the clinic portal to help patients manage chronic pain through activity optimization.

Product and service5 records
1PD Care System
CategoryDigital Therapeutic Platform
Description

A complete Remote Therapeutic Monitoring (RTM) platform that integrates personalized chronic pain treatment and medication management into one single platform, designed for adult patients with chronic pain prescribed by healthcare professionals.

2Paindrainer App
CategoryPrescription Digital Therapeutic (Mobile App)
Description

A prescription-only mobile digital self-management device for adults with chronic pain that enables daily activity and pain logging and delivers personalized AI-powered activity recommendations and rehabilitation exercises.

3Paindrainer Care Portal
CategoryClinician Portal (B2B Platform)
Description

A cloud-based clinician portal through which healthcare professionals prescribe Paindrainer, monitor patient activity, pain and adherence data, and access analytics for remote therapeutic monitoring.

4CARE Program
CategoryDigital Rehabilitation Program
Description

A 12-week structured pain rehabilitation program built into the Paindrainer app that follows evidence-based practices used at leading pain clinics and includes daily activity planning, exercises, relaxation, and mindfulness practices based on Acceptance and Commitment Therapy (ACT).

5Relivra
CategoryConsumer Pain Support App
Description

A consumer-facing app in development intended to provide personal chronic pain support to individuals who are not connected to Paindrainer healthcare providers.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership5 partners
1UC San Diego Health
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading US research hospital and pain clinic that contributed to the development of PainDrainer's PD Care system. Gregory R. Polston, MD, Pain Management Specialist at UC San Diego Health conducted clinical studies using PainDrainer and provided testimonials for the product's effectiveness.

paindrainer.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Prestigious New York-based medical college and healthcare system that partnered with PainDrainer for clinical development. Clinical studies conducted at Weill Cornell Medicine showed 100% of participants reported better understanding of activity-pain relationships.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Massachusetts-based hospital where Antje M. Barreveld, M.D. serves as Medical Director of Pain Management Services. Dr. Barreveld serves as President-elect for American Academy of Pain Medicine and has provided endorsement of PainDrainer.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Swedish university that contributed to the development of PainDrainer. The company was founded at Medicon Village in Lund in 2018. Professor Carl Borrebaeck and Dr. Maria Rosén Klement from Lund University were among the founders.

5Healthtech Nordic
Strategic tierMinorTypeGTM or Marketing Partner
Description

Nordic health technology organization that PainDrainer partners with as part of the Nordic health tech ecosystem.

paindrainer.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers7 records
TypeDirect peer
Description

Digital musculoskeletal (MSK) care platform offering AI-guided exercise therapy, wearable sensors, and 1:1 coaching for chronic back, neck, and joint pain. Closely comparable to PainDrainer in target condition (chronic MSK pain) and use of AI for personalization, but operating at vastly larger scale with enterprise employer contracts.

2Sword Health
TypeDirect peer
Description

Digital MSK and pelvic-health care provider pairing AI with licensed physical therapists and wearable motion sensors. Directly overlaps with PainDrainer in digital-first, AI-assisted chronic pain treatment delivered via employer and health plan channels.

TypeDirect peer
Description

Digital therapy app that uses AI and computer vision to deliver exercise therapy for back pain, COPD, and other chronic conditions — one of the closest analogs to PainDrainer's prescription digital therapeutic for chronic pain.

TypeBroad incumbent
Description

Long-standing virtual chronic-care platform spanning diabetes, hypertension, and MSK conditions, with both AI-driven self-management and human coaching. Comparable as a condition-specific digital therapeutics pioneer, though PainDrainer is narrower in scope.

TypeEmerging player
Description

Digital therapeutics company focused on behavioral health conditions, including Sleepio (insomnia) and Daylight (anxiety). Competes for the same chronic-condition, prescribed-by-clinician DTx category as PainDrainer and pursues similar payer/provider distribution.

6Bold Health
TypeEmerging player
Description

Digital therapeutic company building app-based programs for chronic conditions such as IBS and pelvic pain. Comparable as an emerging prescription-DTx company applying similar scientific evidence thresholds and clinical-app distribution model.

TypeEmerging player
Description

Digital therapeutics company developing prescription apps for chronic conditions, with a comparable regulatory strategy of FDA clearance and prescription-only distribution similar to PainDrainer's PD Care system.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PainDrainer

Digital Therapeutics for Chronic Pain Managementpaindrainer.com

PainDrainer AB operates a CE-marked, FDA-registered prescription digital therapeutic that uses a proprietary AI network to personalize chronic pain management through daily activity-pain correlation analysis. The PD Care System serves US healthcare providers and adult chronic pain patients via subscription, with operations in Sweden and the United States.

What PainDrainer does

PainDrainer AB is a Swedish digital therapeutics company founded in 2018 at Medicon Village in Lund by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement, and Göran Barkfors. The company operates the PD Care System, a prescription-only digital therapeutic for adults (18+) with chronic non-malignant pain lasting longer than three months, including back, neck, fibromyalgia, joint, and nerve pain. The platform combines a patient-facing mobile app with a cloud-based clinic portal (clinic-us.paindrainer.com) that allows healthcare providers to prescribe the intervention and conduct Remote Therapeutic Monitoring (RTM). The system is CE-marked and FDA-registered (Rx-only under 21 CFR Part 11), with HIPAA, GDPR, and SOC2 compliance, and is anchored on a 12-week CARE program built on Acceptance and Commitment Therapy (ACT).

The core technology is a proprietary artificial intelligence network that ingests structured daily activity logs (sleep, work, rest, leisure, exercise), pain scores, medication adherence, and goals, and after approximately seven logged days produces personalized daily recommendations that balance activity with acceptable pain thresholds. The proprietary method is protected by European patent EP 4186064 (allowable) and parallel applications pending in the US, Canada, Japan, and South Korea. The platform architecture supports a future direct-to-consumer product called Relivra, which is positioned for individuals not connected to partner providers. PainDrainer has co-development and clinical-study partnerships with UC San Diego Health, Weill Cornell Medicine, Newton-Wellesley Hospital, and Lund University, and has published peer-reviewed outcomes in Pain Medicine (2023) and Annals of Clinical Case Reports (2022). Named customers/endorsers include clinical leaders at New York Presbyterian Hospital and the American Academy of Pain Medicine.

PainDrainer's business model is a recurring subscription for the consumer app (99 SEK / ~$9–10 USD per month with a 14-day free trial, payable in Sweden via employer friskvårdsbidrag wellness benefits), paired with a prescription-mediated provider channel in the US where RTM services are billed under CMS RTM codes. Commercial rollout into the US market was funded by a SEK 10 million share issue completed in February 2023, supplemented by additional rounds in December 2021 (~USD 1.37M, Almi Invest-led) and March 2025 (~USD 912K with Almi Invest, Rethink Capital, Tramontane Invest). Active geographies are Sweden (EMEA) and the United States (North America), and the company operates with 1–10 employees.

PainDrainer firmographics

Firmographics
Name
PainDrainer
Legal name
Paindrainer AB
Website
https://paindrainer.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
PainDrainer AB operates a CE-marked, FDA-registered prescription digital therapeutic that uses a proprietary AI network to personalize chronic pain management through daily activity-pain correlation analysis. The PD Care System serves US healthcare providers and adult chronic pain patients via subscription, with operations in Sweden and the United States.
Ownership category
akta.pro rank

PainDrainer industry classification

Industry
Product category
Digital Therapeutics for Chronic Pain Management
NAICS
Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511), Home Health Care Services (62161)
SIC
Services-Health Services (8000), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLACANAA
Condition-specific Digital Therapeutics (DTx)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAFABAH
Pain Management Clinics (Interventional & Medical)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

Keywords

  • Digital therapeutics platform
  • Chronic pain management
  • Remote therapeutic monitoring
  • Prescription digital therapeutic
  • AI activity recommendations

Where PainDrainer is headquartered

Location

Headquarters

HQ city
Lund
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

PainDrainer business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Subscription - PD Care System: Monthly subscription model for the PainDrainer app and PD Care system. Users receive a 14-day free trial before subscription charges begin. The subscription provides access to the complete CARE program, personalized recommendations after 7 logged days, and all app features including activity planning, pain tracking, and rehabilitation exercises.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStandard monthly subscription with 14-day free trial

Distribution channels3 records

Marketing channels4 records

PainDrainer product offering

Product offering

Core offering

PainDrainer develops and sells the PD Care System, a prescription-only digital therapeutic and Remote Therapeutic Monitoring (RTM) platform for adults with chronic pain lasting more than three months. The platform combines a patient mobile app, a cloud-based Care Portal for healthcare professionals, and a proprietary AI network that analyzes individual activity and pain data to deliver personalized daily activity recommendations and a 12-week CARE rehabilitation program. The product is registered as a medical device (CE-marked and FDA-registered) and is prescribed by healthcare providers to address conditions such as back pain, neck pain, fibromyalgia, joint pain, and nerve pain.

Product overview

Paindrainer offers a unified digital health platform centered on the PD Care System, combining a prescription-only mobile app for chronic pain patients with a cloud-based Care Portal for healthcare professionals. The platform provides Remote Therapeutic Monitoring (RTM) services, featuring the 12-week CARE Program, AI-powered personalized activity recommendations, rehabilitation exercises, and relaxation/mindfulness practices. Healthcare providers can prescribe the solution through the clinic portal to help patients manage chronic pain through activity optimization.

Differentiator

Problem solved

Functional benefit

Brands

  • PD Care System: A complete Remote Therapeutic Monitoring (RTM) solution designed to integrate personalized treatment and medication management into one single platform for chronic pain management.

Products and services

  • PD Care System A complete Remote Therapeutic Monitoring (RTM) platform that integrates personalized chronic pain treatment and medication management into one single platform, designed for adult patients with chronic pain prescribed by healthcare professionals.
  • Paindrainer App A prescription-only mobile digital self-management device for adults with chronic pain that enables daily activity and pain logging and delivers personalized AI-powered activity recommendations and rehabilitation exercises.
  • Paindrainer Care Portal A cloud-based clinician portal through which healthcare professionals prescribe Paindrainer, monitor patient activity, pain and adherence data, and access analytics for remote therapeutic monitoring.
  • CARE Program A 12-week structured pain rehabilitation program built into the Paindrainer app that follows evidence-based practices used at leading pain clinics and includes daily activity planning, exercises, relaxation, and mindfulness practices based on Acceptance and Commitment Therapy (ACT).
  • Relivra A consumer-facing app in development intended to provide personal chronic pain support to individuals who are not connected to Paindrainer healthcare providers.

Quantifiable outcome

  • 72.5% improved physical function after 12 weeks using PD Care system
  • +4 more outcomes

Companies that use PainDrainer

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

PainDrainer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

PainDrainer partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • UC San Diego HealthcoreStrategic or Co-development PartnerLeading US research hospital and pain clinic that contributed to the development of PainDrainer's PD Care system. Gregory R. Polston, MD, Pain Management Specialist at UC San Diego Health conducted clinical studies using PainDrainer and provided testimonials for the product's effectiveness.
  • Weill Cornell MedicinecoreStrategic or Co-development PartnerPrestigious New York-based medical college and healthcare system that partnered with PainDrainer for clinical development. Clinical studies conducted at Weill Cornell Medicine showed 100% of participants reported better understanding of activity-pain relationships.
  • Newton-Wellesley HospitalcoreStrategic or Co-development PartnerMassachusetts-based hospital where Antje M. Barreveld, M.D. serves as Medical Director of Pain Management Services. Dr. Barreveld serves as President-elect for American Academy of Pain Medicine and has provided endorsement of PainDrainer.
  • Lund University (Lunds Universitet)coreStrategic or Co-development PartnerSwedish university that contributed to the development of PainDrainer. The company was founded at Medicon Village in Lund in 2018. Professor Carl Borrebaeck and Dr. Maria Rosén Klement from Lund University were among the founders.
  • Healthtech NordicminorGTM or Marketing PartnerNordic health technology organization that PainDrainer partners with as part of the Nordic health tech ecosystem.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

PainDrainer competitors and assessment

Company assessment

Direct peers

  • Hinge Health: Digital musculoskeletal (MSK) care platform offering AI-guided exercise therapy, wearable sensors, and 1:1 coaching for chronic back, neck, and joint pain. Closely comparable to PainDrainer in target condition (chronic MSK pain) and use of AI for personalization, but operating at vastly larger scale with enterprise employer contracts.
  • Sword Health: Digital MSK and pelvic-health care provider pairing AI with licensed physical therapists and wearable motion sensors. Directly overlaps with PainDrainer in digital-first, AI-assisted chronic pain treatment delivered via employer and health plan channels.
  • Kaia Health: Digital therapy app that uses AI and computer vision to deliver exercise therapy for back pain, COPD, and other chronic conditions — one of the closest analogs to PainDrainer's prescription digital therapeutic for chronic pain.

Broad incumbents

  • Omada Health: Long-standing virtual chronic-care platform spanning diabetes, hypertension, and MSK conditions, with both AI-driven self-management and human coaching. Comparable as a condition-specific digital therapeutics pioneer, though PainDrainer is narrower in scope.

Emerging players

  • Big Health: Digital therapeutics company focused on behavioral health conditions, including Sleepio (insomnia) and Daylight (anxiety). Competes for the same chronic-condition, prescribed-by-clinician DTx category as PainDrainer and pursues similar payer/provider distribution.
  • Bold Health: Digital therapeutic company building app-based programs for chronic conditions such as IBS and pelvic pain. Comparable as an emerging prescription-DTx company applying similar scientific evidence thresholds and clinical-app distribution model.
  • Mahana Therapeutics: Digital therapeutics company developing prescription apps for chronic conditions, with a comparable regulatory strategy of FDA clearance and prescription-only distribution similar to PainDrainer's PD Care system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PainDrainer social profiles

Digital presence

PainDrainer compliance and trust

Trust signal

Compliance6 records

PainDrainer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PainDrainer leadership team

Management profile

Number of profiles

Profiles4 records

PainDrainer funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PainDrainer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PainDrainer

What does PainDrainer do?

PainDrainer develops and sells the PD Care System, a prescription-only digital therapeutic and Remote Therapeutic Monitoring (RTM) platform for adults with chronic pain lasting more than three months. The platform combines a patient mobile app, a cloud-based Care Portal for healthcare professionals, and a proprietary AI network that analyzes individual activity and pain data to deliver personalized daily activity recommendations and a 12-week CARE rehabilitation program. The product is registered as a medical device (CE-marked and FDA-registered) and is prescribed by healthcare providers to address conditions such as back pain, neck pain, fibromyalgia, joint pain, and nerve pain.

Is PainDrainer a public or private company?

PainDrainer is a private company. It is classified as venture growth investor backed and is currently operating.

When was PainDrainer founded?

PainDrainer was founded in 2018. It employs 1 to 10 people.

Where is PainDrainer based?

PainDrainer is headquartered in Lund, Sweden, in the Europe region.

How does PainDrainer make money?

One revenue line is on record: subscription - PD Care System.

Who are PainDrainer's main competitors?

Direct peers on record are Hinge Health, Sword Health and Kaia Health. Omada Health is listed as a broad incumbent. Emerging players are Big Health, Bold Health and Mahana Therapeutics.

Does PainDrainer have an API?

No public API is recorded for PainDrainer.

What industry is PainDrainer in?

PainDrainer's product category is Digital Therapeutics for Chronic Pain Management. Its primary akta.pro industry code is HLACANAA, Condition-specific Digital Therapeutics (DTx), with a secondary code of HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms. Its NAICS code is 54151 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BiostockPanel: The Digital Health Paradox: Booming Developments, Broken Investment ModelsA panel discussion titled 'The Digital Health Paradox: Booming Developments, Broken Investment Models' was held at Health Tech Hub Copenhagen, bringing together industry figures to examine whether current digital health business models are sustainable and how AI-powered products might reinvigorate investor interest. The conversation focused on the challenges preventing Nordic and European digital health companies from scaling beyond pilot projects within fragmented healthcare systems. Panelists included Ann-Charlotte Beckman (LSI), Erik Frick (Paindrainer), and Zoe Zhu (EQT Group), with Nicolas Bouchet moderating.news.cision.comPaindrainer AB raises 9.5 million in an oversubscribed share issuePaindrainer AB completed a 9.5 million SEK share issue oversubscribed by Almi Invest, Fredrik Sjödin, ReThink Capital, and existing shareholders. Proceeds will fund the US commercial rollout of its AI-powered remote therapeutic monitoring system and clinical trials with health organizations.news.cision.comMassive Entertainment expands its collaboration with the local health-tech company Paindrainer ABMassive Entertainment and Paindrainer AB will launch a joint pilot test program for its employees. Paindrainer's app is FDA registered as a Medical Device Class 1 and won the Nordic Health App Award 2023. The collaboration aims to scale into companies with sustainable employee policies.news.cision.comPaindrainer AB appoints Linda Nyberg as new Board MemberPaindrainer AB appointed Linda Nyberg as a new board member. She is currently chief communications officer at Novatron Fusion Group and brings experience from tech and life science. The company's Paindrainer app is a digital therapeutics tool for chronic pain.OresundstartupsPaindrainer secured funding for AI based chronic pain management appPaindrainer, a Lund-based digital therapeutics company, secured 10 million SEK (€880,000) through a share issue to support the launch of its AI-based chronic pain management app. The funding will accelerate the integration of wearables into the product and facilitate market entry in the USA, where there is high demand for drug-free remote therapeutic monitoring solutions.news.cision.comSuccessful outcome of share issue in Paindrainer ABPaindrainer AB successfully completed a share issue of 10 MSEK to fund the commercial rollout of its digital self-management tool for chronic pain. The capital will be used to accelerate the integration of wearables into the product to improve user engagement and data accuracy. This funding supports the company's strategy to enter the US market and partner directly with clinics.news.cision.comPaindrainer AB appoints new Board Member Philip SibergPaindrainer AB announced the appointment of Philip Siberg to its Board of Directors, effective February 1, 2023. Siberg is a serial digital entrepreneur in the Life Science industry with a background in venture capital and M&A advisory, and previously served as CEO and co-founder of Nasdaq-listed Coala Life. The company stated the appointment brings expertise to support its global expansion and commercialization efforts in the Remote Therapeutic Monitoring market.news.cision.comScientific publication reports clinical evidence for PainDrainer’s unique pain appA published clinical study from UC San Diego Health Science and PainDrainer AB reports significant improvements in quality of life and pain reduction in chronic pain patients after about six weeks of using the app. The study is the first clinical evidence for PainDrainer, an AI-powered digital pain coach. The company has ongoing studies with Weill Cornell Medicine, Newton-Wellesley Hospital, and Skåne University Hospital.news.cision.comPainDrainer AB is recruiting a new CTO with commercial experience of App developmentPainDrainer AB is recruiting a new CTO, Jakob Berglund, who will take over on June 11. He brings extensive experience in creating and selling digital apps, most recently from FlatFrog Laboratories. The company's digital pain coach has shown clinical evidence of improved quality of life and reduced pain in chronic patients.news.cision.comHealthtech company PainDrainer AB recruits new CEO with experience from commercialization of digital servicesErik Frick was appointed CEO of PainDrainer AB on April 25, tasked with commercializing its AI-based digital self-management tool for chronic pain patients. He previously served as Vice President at Resurs Bank, where he led the commercialization of a fintech app with about 250,000 users. The company aims to expand its healthtech business under his leadership.